Benzofuran derived HIV protease inhibitors

Details Benzofuran derived HIV protease inhibitors Benzofuran derived HIV protease inhibitors

2011-07-19

2011-07-19

Shameem, Golam M (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S429000, C549S456000, C549S465000, C514S449000, C514S461000, C514S469000

Reexamination Certificate

active

07981929

ABSTRACT:
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.

REFERENCES:
patent: 6649651 (2003-11-01), Wigerinck et al.
patent: 7157495 (2007-01-01), Wang et al.
patent: 7378441 (2008-05-01), Eissenstat et al.
patent: 7507763 (2009-03-01), Eissenstat et al.
patent: 2006/0293286 (2006-12-01), Erickson et al.
patent: 2007/0010489 (2007-01-01), Arimilli et al.
patent: WO 2006/108879 (2006-10-01), None

Affiliated with

Also associated with

Rating

Benzofuran derived HIV protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzofuran derived HIV protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzofuran derived HIV protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2670516